Homepage | Forward to a Friend | Make a Donation |
|
eLetter #669 | July 22, 2016 |
|
The National Patient Education Conference is Just One Week Away!
The Scleroderma Foundation’s National Patient Education
Conference in New Orleans, Louisiana is only one week away! We’re looking forward to a productive and
exciting weekend, and we hope you are too!
If you need it, the Conference website offers some excellent
resources for travel information. Also,
be sure to keep up with all the action at our Twitter, Facebook and Instagram
pages. While in NOLA, we encourage you to use the #unmaskthecure hashtag. We’ll keep you updated throughout
the weekend with news, photos and more!
And if you find yourself in the New Orleans-area next week,
stop by! We accept walk-in registration
onsite.
Let the good times roll!
See you there!
|
11 Ways to Get Faster Sleep
Do you spend a majority of your nights tossing and turning, struggling to catch some zzz's? You're not alone. According to the National Sleep Foundation, 45 percent of Americans experience poor or insufficient sleep.
Click here for tips >>
|
How Your Gut Controls Your Brain
If you think your brain is controlling the show, think again! Whether you're suffering from anxiety or are just in a crabby mood, before you start poking around your head as if looking for answers, you might do well to aim a little lower: your gut.
Click here for more >>
|
A New Clue why Autoimmune Diseases Target Women
Researchers have long searched to understand why diseases like lupus and rheumatoid arthritis disproportionately affect women. Now, findings from the Oklahoma Medical Research Foundation shed some new light. Sjögren’s, lupus, Rheumatoid arthritis (RA) and more than 80 other disorders are known as “autoimmune” diseases, conditions in which the immune system becomes unbalanced and turns on the body instead of protecting it. Many of these illnesses strike women at much higher rates than men.
Click here to read more >>
|
|
|
Advertisement
|
Disclaimer: The Scleroderma Foundation in no way
endorses any drugs, treatments, clinical trials, or studies reported in the eLetter. Information is
provided to keep the readers informed. Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with the reader’s physician(s) for proper evaluation and treatment.
|
|
|